Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT vs IV Ketamine in TRD
NCT07526454Completed
- Sponsor
- Tanta University
- Start
- Jul 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ketamine in major depressive disorder (MDD) (2 arms), sponsored by Tanta University. Primary endpoint: Montgomery-Åsberg Depression Rating Scale. Started Jul 2025; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07526454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07526454.